Overall, this meta-analysis suggests that CT radiomics-based models have the potential to be a valuable tool in predicting EGFR mutation status in NSCLC patients, but further research is needed to fully establish their clinical utility and address the limitations and gaps in the current literature. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.